ResMed Enhances CPAP Therapy With Its First Fabric Mask, Designed To Make It Easier For People To Embrace Their Treatment And Improve Overall Sleep Health
ResMed Enhances CPAP Therapy With Its First Fabric Mask, Designed To Make It Easier For People To Embrace Their Treatment And Improve Overall Sleep Health
ResMed (NYSE:RMD, ASX: RMD))))), the world's leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with the launch of the AirTouch N30i. Designed to create a natural and comfortable sleep experience for users, the AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design for optimal comfort in a tube-up design.
瑞思迈（纽交所：RMD, ASX: RMD))))))，全球领先的健康科技公司，专注于睡眠、呼吸和家庭护理，今日宣布推出AirTouch N30i，这是瑞思迈在CPAP（持续气道正压）掩膜版-半导体创新方面的首次尝试。AirTouch N30i旨在为用户创造自然舒适的睡眠体验，采用包裹在织物中的框架，具有柔软、透气和吸湿性设计，以实现管上设计的最佳舒适度。
Sleep apnea affects more than 54 million people in the United States and nearly one billion people worldwide1. This chronic sleep-related breathing disorder can impair daily functioning and significantly increase the risk of serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke2.
睡眠呼吸暂停症在美国影响超过5千4百万人，在全球范围内近10亿人受到影响。这种慢性与睡眠有关的呼吸障碍可能会影响日常功能并显著增加严重合并症的风险，如高血压、糖尿病、心血管疾病和中风。
